⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SBFM News
Sunshine Biopharma Inc.
Form 8-K
sec.gov
SBFM
SBFMW
Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering
accessnewswire.com
SBFM
Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering
accessnewswire.com
SBFM
Form 8-K
sec.gov
QUCY
SBFM
FIEE
SOWG
INDP
BTTC
VIVK
BGMS
PPBT
YHC
Form 8-K
sec.gov
SBFMW
SBFM
Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year
accessnewswire.com
SBFM
Form 8-K
sec.gov
SBFM
SBFMW
Form 8-K
sec.gov
SBFMW
SBFM
Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)
accessnewswire.com
SBFM
SBFM
Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea
accessnewswire.com
SBFM